Status:
COMPLETED
Nijmegen Antihypertensive Management Improvement Study
Lead Sponsor:
Radboud University Medical Center
Conditions:
Primary Hypertension
Eligibility:
All Genders
18-65 years
Phase:
PHASE4
Brief Summary
High blood pressure is an important risk factor for diseases of heart and blood vessels like myocardial infarction and stroke. Many patients are not treated to target blood pressures, even though good...
Detailed Description
Population-wide elimination of hypertension would reduce the incidence of all stroke, MI and heart failure with 30 to 50% and contribute to a reduction of between 25 to 50% of the total mortality rela...
Eligibility Criteria
Inclusion
- Age 18-65 years with newly diagnosed hypertension in general practice
- hypertension is defined as either \> 140 mm Hg systolic or \> 90 mm Hg diastolic on three separate days.
Exclusion
- History of cardiovascular disease (transient ischemic attack (TIA), stroke, myocardial infarction (MI), peripheral arterial disease (PAD), atrial fibrillation (AF), angina pectoris (AP), Diabetes Mellitus)
- Unable to understand and/or speak Dutch
- Severe hypertension (\> 200/120 mmHg)
- Irregular pulse
- Use of antihypertensive medication
- Contraindication to one of the trial drugs
- Serious suspicion on secondary hypertension
Key Trial Info
Start Date :
August 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2011
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT00457483
Start Date
August 1 2007
End Date
March 1 2011
Last Update
February 14 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nijmegen monitoring project coordinated from Nijmegen
Nijmegen, Netherlands